Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome.

about

Effectiveness of high-dose i.v. immunoglobulin therapy for pregnant women with aspirin-heparin-resistant secondary antiphospholipid syndrome.

P2860

Q53691739-8A6933AA-E24A-4652-BA61-AFBCE108EE96

P2860

Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome.

Item

http://www.wikidata.org/entity/Q55340983

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Intravenous immunoglobulin the ...... ant antiphospholipid syndrome.

@en

Intravenous immunoglobulin the ...... ant antiphospholipid syndrome.

@nl

type

Item

label

Intravenous immunoglobulin the ...... ant antiphospholipid syndrome.

@en

Intravenous immunoglobulin the ...... ant antiphospholipid syndrome.

@nl

prefLabel

Intravenous immunoglobulin the ...... ant antiphospholipid syndrome.

@en

Intravenous immunoglobulin the ...... ant antiphospholipid syndrome.

@nl

P1476

Intravenous immunoglobulin the ...... ant antiphospholipid syndrome.

@en

P2093

Hideto Yamada

http://www.w3.org/2001/XMLSchema#string

Hisanori Minakami

http://www.w3.org/2001/XMLSchema#string

Noriaki Sakuragi

http://www.w3.org/2001/XMLSchema#string

Shigeki Shimada

http://www.w3.org/2001/XMLSchema#string

Takashi Yamada

http://www.w3.org/2001/XMLSchema#string

Tatsuya Atsumi

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.

In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanism.

Intravenous immunoglobulin therapy of antiphospholipid syndrome.

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

Management of antiphospholipid syndrome.

IVIG in APS pregnancy.

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms.

In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormone-dependent human chorionic gonadotrophin release by cultured trophoblast cells.

P2888

s12522-010-0056-3

P304

217-221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12522-010-0056-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008317524

http://www.w3.org/2001/XMLSchema#string

P698

29699347

http://www.w3.org/2001/XMLSchema#string

P921

aspirin

P932

5904649

http://www.w3.org/2001/XMLSchema#string

Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome.

about

P2860

P2860

Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932